Abbott Laboratories (ABT) WACC Analysis

As of June 14, 2025, Abbott Laboratories (ABT) carries a Weighted Average Cost of Capital (WACC) of 7.4%. WACC reflects the blended rate Abbott Laboratories must pay to both equity and debt holders.

Within that, the cost of equity is 6.4%, the cost of debt is 4.0%, and the effective tax rate is 14.0%.

Breakdown of WACC Components

• Long-term bond rate: 3.9% – 4.4%
• Equity market risk premium: 4.6% – 5.6%
• Adjusted beta: 0.56 – 0.72
• Additional risk adjustment: 0.0% – 0.5%
• Debt-to-equity ratio: 0.06

What It Means for Investors

With a selected WACC of 7.4%, Abbott Laboratories must ensure any new investment returns exceed this threshold to generate shareholder value. This level reflects an attractive low cost of capital.